Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 194

1.

Assessment of a New ROS1 Immunohistochemistry Clone (SP384) for the Identification of ROS1 Rearrangements in Non-Small Cell Lung Carcinoma Patients: the ROSING Study.

Conde E, Hernandez S, Martinez R, Angulo B, De Castro J, Collazo-Lorduy A, Jimenez B, Muriel A, Mate JL, Moran T, Aranda I, Massuti B, Rojo F, Domine M, Sansano I, Garcia F, Felip E, Mancheño N, Juan O, Sanz J, Gonzalez-Larriba JL, Atienza-Cuevas L, Arriola-Arellano E, Abdulkader I, Garcia-Gonzalez J, Camacho C, Rodriguez-Abreu D, Teixido C, Reguart N, Gonzalez-Piñeiro A, Lazaro-Quintela M, Lozano MD, Gurpide A, Gomez-Roman J, Lopez-Brea M, Pijuan L, Salido M, Arriola E, Company A, Insa A, Esteban-Rodriguez I, Saiz M, Azkona E, Alvarez R, Artal A, Plaza ML, Aguiar D, Enguita AB, Benito A, Paz-Ares L, Garrido P, Lopez-Rios F.

J Thorac Oncol. 2019 Jul 23. pii: S1556-0864(19)30562-3. doi: 10.1016/j.jtho.2019.07.005. [Epub ahead of print]

2.

Radium-223 international early access program: results from the Spanish subset.

Carles J, Méndez MJ, Pinto Á, Sáez MI, Arranz JA, Maroto P, López-Criado P, Mellado B, Donas JG, Hernando S, León L, Del Alba AG, Laínez N, Esteban E, Reynés G, Pérez-Gracia JL, Germà JR, López-Brea M, Pérez-Valderrama B, Moretones C, Castellano D.

Future Oncol. 2018 Jan;14(1):41-50. doi: 10.2217/fon-2017-0297. Epub 2017 Dec 13.

PMID:
29232987
3.

Consensus Recommendations from the Spanish Germ Cell Cancer Group on the Use of High-dose Chemotherapy in Germ Cell Cancer.

González-Billalabeitia E, Sepúlveda JM, Maroto P, Aparicio J, Arranz JA, Esteban E, Gironés R, López-Brea M, Mendez-Vidal MJ, Pinto A, Sastre J, de Prado DS, Terrasa J, Vázquez S, Powles T, Beyer J, Castellano D, Del Muro XG; Spanish Germ Cell Cancer Group and the Spanish Oncology Genitourinary Group.

Eur Urol Focus. 2017 Apr;3(2-3):280-286. doi: 10.1016/j.euf.2016.07.002. Epub 2016 Jul 18. Review.

PMID:
28753776
4.

Introducción.

López-Brea M.

Med Clin (Barc). 2016 Apr;146 Suppl 1:1. doi: 10.1016/S0025-7753(16)30255-X. Spanish. No abstract available.

PMID:
27426240
5.

Antimicrobial susceptibility of 6 antimicrobial agents in Helicobacter pylori clinical isolates by using EUCAST breakpoints compared with previously used breakpoints.

Alarcón T, Urruzuno P, Martínez MJ, Domingo D, Llorca L, Correa A, López-Brea M.

Enferm Infecc Microbiol Clin. 2017 May;35(5):278-282. doi: 10.1016/j.eimc.2016.02.010. Epub 2016 Mar 24. English, Spanish.

PMID:
27017059
6.

Impact on clinical practice of the implementation of guidelines for the toxicity management of targeted therapies in kidney cancer. The protect-2 study.

Lainez N, García-Donas J, Esteban E, Puente J, Sáez MI, Gallardo E, Pinto-Marín Á, Vázquez-Estévez S, León L, García-Carbonero I, Suárez-Rodríguez C, Molins C, Climent-Duran MA, Lázaro-Quintela M, González Del Alba A, Méndez-Vidal MJ, Chirivella I, Afonso FJ, López-Brea M, Sala-González N, Domenech M, Basterretxea L, Santander-Lobera C, Gil-Arnáiz I, Fernández O, Caballero-Díaz C, Mellado B, Marrupe D, García-Sánchez J, Sánchez-Escribano R, Fernández Parra E, Villa Guzmán JC, Martínez-Ortega E, Belén González M, Morán M, Suarez-Paniagua B, Lecumberri MJ, Castellano D.

BMC Cancer. 2016 Feb 22;16:135. doi: 10.1186/s12885-016-2084-9.

7.

Validation of the International Metastatic Renal-Cell Carcinoma Database Consortium (IMDC) prognostic model for first-line pazopanib in metastatic renal carcinoma: the Spanish Oncologic Genitourinary Group (SOGUG) SPAZO study.

Pérez-Valderrama B, Arranz Arija JA, Rodríguez Sánchez A, Pinto Marín A, Borrega García P, Castellano Gaunas DE, Rubio Romero G, Maximiano Alonso C, Villa Guzmán JC, Puertas Álvarez JL, Chirivella González I, Méndez Vidal MJ, Juan Fita MJ, León-Mateos L, Lázaro Quintela M, García Domínguez R, Jurado García JM, Vélez de Mendizábal E, Lambea Sorrosal JJ, García Carbonero I, González del Alba A, Suárez Rodríguez C, Jiménez Gallego P, Meana García JA, García Marrero RD, Gajate Borau P, Santander Lobera C, Molins Palau C, López Brea M, Fernández Parra EM, Reig Torras O, Basterretxea Badiola L, Vázquez Estévez S, González Larriba JL.

Ann Oncol. 2016 Apr;27(4):706-11. doi: 10.1093/annonc/mdv601. Epub 2015 Dec 9.

PMID:
26658889
8.

Eosinophilic annular erythema in a patient with metastatic prostate adenocarcinoma.

González-López MA, López-Escobar M, Fernández-Llaca H, González-Vela MC, López-Brea M.

Int J Dermatol. 2015 Mar;54(3):e80-2. doi: 10.1111/ijd.12640. Epub 2014 Dec 16. No abstract available.

PMID:
25515818
9.

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

Aparicio J, Maroto P, García del Muro X, Sánchez-Muñoz A, Gumà J, Margelí M, Sáenz A, Sagastibelza N, Castellano D, Arranz JA, Hervás D, Bastús R, Fernández-Aramburo A, Sastre J, Terrasa J, López-Brea M, Dorca J, Almenar D, Carles J, Hernández A, Germà JR.

Ann Oncol. 2014 Nov;25(11):2173-8. doi: 10.1093/annonc/mdu437. Epub 2014 Sep 10.

PMID:
25210015
10.

Synchronous versus metachronous brain metastasis from testicular germ cell tumors (TGCT): an analysis from the Spanish Germ Cell Cancer Group data base.

Girones R, Aparicio J, Roure P, Germa-Lluch JR, García Del Muro X, Vazquez-Estevez S, Saenz A, Sastre J, Arranz Arija J, Gallardo E, Gonzalez-Billalabeitia E, Sanchez-Hernandez A, Terrasa J, Hernandez A, Santander C, Cillan E, Sagastibelza N, Almenar-Cubells D, Lopez Brea M, Maroto JP; Spanish Germ Cell Cancer Group (SGCCG).

Clin Transl Oncol. 2014 Nov;16(11):959-65. doi: 10.1007/s12094-014-1179-5. Epub 2014 Apr 10.

PMID:
24719184
11.

Adjuvant MAGE-A3 immunotherapy in resected non-small-cell lung cancer: phase II randomized study results.

Vansteenkiste J, Zielinski M, Linder A, Dahabreh J, Gonzalez EE, Malinowski W, Lopez-Brea M, Vanakesa T, Jassem J, Kalofonos H, Perdeus J, Bonnet R, Basko J, Janilionis R, Passlick B, Treasure T, Gillet M, Lehmann FF, Brichard VG.

J Clin Oncol. 2013 Jul 1;31(19):2396-403. doi: 10.1200/JCO.2012.43.7103. Epub 2013 May 28.

PMID:
23715567
12.

Burkholderia cepacia complex infection in an Adult Cystic Fibrosis unit in Madrid.

Correa-Ruiz A, Girón R, Buendía B, Medina-Pascual MJ, Valenzuela C, López-Brea M, Sáez-Nieto JA.

Enferm Infecc Microbiol Clin. 2013 Dec;31(10):649-54. doi: 10.1016/j.eimc.2012.12.001. Epub 2013 Mar 23.

PMID:
23528342
13.

[Leptotrichia goodfellowii wound infection after a dog bite].

Guiu A, Domingo D, Correa A, López-Brea M.

Rev Esp Quimioter. 2012 Sep;25(3):220-1. Spanish. No abstract available.

14.

[Pneumococcal bacteremia in adult patients at a hospital in Madrid: serotypes and susceptibility].

Correa AM, Sanz JC, de Las Cuevas C, Guiu A, Domingo D, Alarcón T, López-Brea M.

Rev Esp Quimioter. 2012 Jun;25(2):155-60. Spanish.

15.

Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption.

Megraud F, Coenen S, Versporten A, Kist M, Lopez-Brea M, Hirschl AM, Andersen LP, Goossens H, Glupczynski Y; Study Group participants.

Gut. 2013 Jan;62(1):34-42. doi: 10.1136/gutjnl-2012-302254. Epub 2012 May 12.

PMID:
22580412
16.

Abdominal abscess due to NDM-1-producing Klebsiella pneumoniae in Spain.

Oteo J, Domingo-García D, Fernández-Romero S, Saez D, Guiu A, Cuevas O, Lopez-Brea M, Campos J.

J Med Microbiol. 2012 Jun;61(Pt 6):864-7. doi: 10.1099/jmm.0.043190-0. Epub 2012 Mar 1.

PMID:
22383442
17.

Cost-effectiveness evaluation of sunitinib as first-line targeted therapy for metastatic renal cell carcinoma in Spain.

Calvo Aller E, Maroto P, Kreif N, González Larriba JL, López-Brea M, Castellano D, Martí B, Díaz Cerezo S.

Clin Transl Oncol. 2011 Dec;13(12):869-77. doi: 10.1007/s12094-011-0748-0.

PMID:
22126730
18.

Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.

Aparicio J, Maroto P, del Muro XG, Gumà J, Sánchez-Muñoz A, Margelí M, Doménech M, Bastús R, Fernández A, López-Brea M, Terrassa J, Meana A, del Prado PM, Sastre J, Satrústegui JJ, Gironés R, Robert L, Germà JR.

J Clin Oncol. 2011 Dec 10;29(35):4677-81. doi: 10.1200/JCO.2011.36.0503. Epub 2011 Oct 31.

PMID:
22042940
19.
20.

[Antibiotic susceptibility of Corynebacterium macginleyi strains causing conjunctivitis].

Espínola M, Somodevilla A, Domingo D, Alarcón T, López-Brea M.

Rev Esp Quimioter. 2010 Dec;23(4):196-200. Spanish.

21.

High prevalence of clarithromycin-resistant Helicobacter pylori strains and risk factors associated with resistance in Madrid, Spain.

Agudo S, Pérez-Pérez G, Alarcón T, López-Brea M.

J Clin Microbiol. 2010 Oct;48(10):3703-7. doi: 10.1128/JCM.00144-10. Epub 2010 Jul 28.

22.

Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine.

Viñolas N, Provencio M, Reguart N, Cardenal F, Alberola V, Sánchez-Torres JM, Barón FJ, Cobo M, Maestu I, Moreno I, Mesía C, Izquierdo A, Felip E, López-Brea M, Márquez A, Sánchez-Ronco M, Tarón M, Santarpia MC, Rosell R; Spanish Lung Cancer Group.

Lung Cancer. 2011 Feb;71(2):191-8. doi: 10.1016/j.lungcan.2010.05.005.

PMID:
20627363
23.

Detection of Helicobacter pylori and clarithromycin resistance in gastric biopsies of pediatric patients by using a commercially available real-time polymerase chain reaction after NucliSens semiautomated DNA extraction.

Agudo S, Alarcón T, Urruzuno P, Martínez MJ, López-Brea M.

Diagn Microbiol Infect Dis. 2010 Jul;67(3):213-9. doi: 10.1016/j.diagmicrobio.2010.02.021.

PMID:
20542201
24.

[High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children].

Agudo S, Alarcón T, Cibrelus L, Urruzuno P, Martínez MJ, López-Brea M.

Rev Esp Quimioter. 2009 Jun;22(2):88-92.

25.

SEOM guidelines for the management of non-small-cell lung cancer (NSCLC).

Felip E, Garrido P, Trigo JM, López-Brea M, Paz-Ares L, Provencio M, Isla D; Spanish Society of Medical Oncology.

Clin Transl Oncol. 2009 May;11(5):284-9.

PMID:
19451061
26.

Chemotherapy as an alternative to radiotherapy in the treatment of stage IIA and IIB testicular seminoma: a Spanish Germ Cell Cancer Group Study.

Garcia-del-Muro X, Maroto P, Gumà J, Sastre J, López Brea M, Arranz JA, Lainez N, Soto de Prado D, Aparicio J, Piulats JM, Pérez X, Germá-Lluch JR.

J Clin Oncol. 2008 Nov 20;26(33):5416-21. doi: 10.1200/JCO.2007.15.9103. Epub 2008 Oct 20.

PMID:
18936476
27.

Cetuximab, its clinical use and future perspectives.

Rivera F, Vega-Villegas ME, López-Brea MF.

Anticancer Drugs. 2008 Feb;19(2):99-113. doi: 10.1097/CAD.0b013e3282f23287. Review.

PMID:
18176106
28.

Current situation of Panitumumab, Matuzumab, Nimotuzumab and Zalutumumab.

Rivera F, Vega-Villegas ME, Lopez-Brea MF, Marquez R.

Acta Oncol. 2008;47(1):9-19. Review.

PMID:
18097777
29.

Inhibitory effect of Gram-negative and Gram-positive microorganisms against Helicobacter pylori clinical isolates.

López-Brea M, Alarcón T, Domingo D, Díaz-Regañón J.

J Antimicrob Chemother. 2008 Jan;61(1):139-42. Epub 2007 Oct 26.

PMID:
17965421
30.

Randomized phase II study of cisplatin and 5-FU continuous infusion (PF) versus cisplatin, UFT and vinorelbine (UFTVP) as induction chemotherapy in locally advanced squamous cell head and neck cancer (LA-SCHNC).

Rivera F, Vega-Villegas ME, López-Brea M, Isla D, Mayorga M, Galdós P, Rubio A, Del Valle A, García-Reija F, García-Montesinos B, Rodríguez-Iglesias J, Mayordomo J, Rama J, Saiz-Bustillo R, Sanz-Ortiz J.

Cancer Chemother Pharmacol. 2008 Jul;62(2):253-61. Epub 2007 Sep 28.

PMID:
17901953
31.

[Antibiotic therapy with probiotics].

Lopez-Brea M, Domingo D.

Rev Esp Quimioter. 2007 Jun;20(2):170-81. Review. Spanish. No abstract available.

32.

Detection of clarithromycin-resistant Helicobacter pylori in frozen gastric biopsies from pediatric patients by a commercially available fluorescent in situ hybridization.

Vega AE, Alarcón T, Domingo D, López-Brea M.

Diagn Microbiol Infect Dis. 2007 Dec;59(4):421-3. Epub 2007 Sep 18.

PMID:
17878066
33.

Detection of decreased susceptibility to fluoroquinolones in Salmonella spp. by five different methods including real-time polymerase chain reaction (PCR).

Aznar E, Alarcon T, Buendía B, García-Peñuela E, López-Brea M.

Int J Antimicrob Agents. 2007 Jul;30(1):67-71. Epub 2007 Apr 2.

PMID:
17400429
34.

Chemotherapy of advanced gastric cancer.

Rivera F, Vega-Villegas ME, López-Brea MF.

Cancer Treat Rev. 2007 Jun;33(4):315-24. Epub 2007 Mar 21. Review.

PMID:
17376598
35.

Long term results of a phase II trial of induction chemotherapy with uracil-ftegafur (UFT), vinorelbine and cisplatin (UFTVP) followed by radiotherapy concomitant with UFT and carboplatin (RT/UFTJ) in non-resectable locally advanced (stage IV-B) squamous cell head and neck carcinoma and peripheral blood stem cell support (PBSCS) with febrile neutropenia.

Rivera F, Vega-Villegas ME, López-Brea MF, García-Castaño A, de Juan A, Ramos FJ, Collado A, Galdós P, Rubio A, del Valle A, Rama J, Mayorga M, Sanz-Ortiz J.

Clin Transl Oncol. 2007 Jan;9(1):40-7. Erratum in: Clin Transl Oncol. 2007 Mar;9(3):202.

PMID:
17272229
36.

[Pandoraea pulmonicola isolation in patients with cystic fibrosis].

Pérez de Ayala-Balzola A, Buendía-Moreno B, Girón-Moreno RM, López-Brea M.

Enferm Infecc Microbiol Clin. 2006 Aug-Sep;24(7):473-4. Spanish. No abstract available.

PMID:
16956543
37.

[Susceptibility pattern of Acinetobacter baumannii clinical isolates in Madrid vs. Hong Kong].

García-Peñuela E, Aznar E, Alarcón T, López-Brea M.

Rev Esp Quimioter. 2006 Mar;19(1):45-50. Spanish.

38.

[Susceptibility of 36 Helicobacter pylori clinical isolates to four first-line antibiotics and virulence factors].

Díaz-Reganon J, Alarcón T, Domingo D, López-Brea M.

Rev Esp Quimioter. 2006 Mar;19(1):34-8. Spanish.

39.

[In vitro activity of furazolidone and nitrofurantoin in Helicobacter pylori clinical isolates and study of mutation rate].

Alarcón T, de la Obra P, Domingo D, García-Campos JA, Díaz-Regañón J, López-Brea M.

Rev Esp Quimioter. 2005 Dec;18(4):313-8. Spanish.

40.

[Helicobacter pylori infection: Nobel Prize in Medicine].

López-Brea M.

Rev Esp Quimioter. 2005 Dec;18(4):271-2. Spanish. No abstract available.

41.

[Resistance of Mycobacterium tuberculosis in a four-year period in a Madrid hospital].

Aznar E, Domingo D, Abanades S, García-Peñuela E, López-Brea M.

Rev Esp Quimioter. 2005 Sep;18(3):222-5. Spanish.

42.

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

Aparicio J, Germà JR, García del Muro X, Maroto P, Arranz JA, Sáenz A, Barnadas A, Dorca J, Gumà J, Olmos D, Bastús R, Carles J, Almenar D, Sánchez M, Paz-Ares L, Satrústegui JJ, Mellado B, Balil A, López-Brea M, Sánchez A; Second Spanish Germ Cell Cancer Cooperative Group.

J Clin Oncol. 2005 Dec 1;23(34):8717-23. Epub 2005 Oct 31.

PMID:
16260698
43.

Fibroblast growth factor receptor 3 is overexpressed in urinary tract carcinomas and modulates the neoplastic cell growth.

Gómez-Román JJ, Saenz P, Molina M, Cuevas González J, Escuredo K, Santa Cruz S, Junquera C, Simón L, Martínez A, Gutiérrez Baños JL, López-Brea M, Esparza C, Val-Bernal JF.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):459-65. Erratum in: Clin Cancer Res. 2005 Apr 15;11(8):3149. Molina, Miguel [added].

44.

Community-acquired urinary tract infection caused by vancomycin-resistant Enterococcus faecalis clinical isolate.

Aznar E, Buendía B, García-Peñuela E, Escudero E, Alarcón T, López-Brea M.

Rev Esp Quimioter. 2004 Sep;17(3):263-5.

45.

Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer.

Isla D, Sarries C, Rosell R, Alonso G, Domine M, Taron M, Lopez-Vivanco G, Camps C, Botia M, Nuñez L, Sanchez-Ronco M, Sanchez JJ, Lopez-Brea M, Barneto I, Paredes A, Medina B, Artal A, Lianes P.

Ann Oncol. 2004 Aug;15(8):1194-203.

PMID:
15277258
46.

Functional adaptation of BabA, the H. pylori ABO blood group antigen binding adhesin.

Aspholm-Hurtig M, Dailide G, Lahmann M, Kalia A, Ilver D, Roche N, Vikström S, Sjöström R, Lindén S, Bäckström A, Lundberg C, Arnqvist A, Mahdavi J, Nilsson UJ, Velapatiño B, Gilman RH, Gerhard M, Alarcon T, López-Brea M, Nakazawa T, Fox JG, Correa P, Dominguez-Bello MG, Perez-Perez GI, Blaser MJ, Normark S, Carlstedt I, Oscarson S, Teneberg S, Berg DE, Borén T.

Science. 2004 Jul 23;305(5683):519-22.

48.

[Plants with antimicrobial action].

Domingo D, López-Brea M.

Rev Esp Quimioter. 2003 Dec;16(4):385-93. Review. Spanish. No abstract available.

49.

[Susceptibility of Campylobacter jejuni clinical isolates from children to eight antibiotics].

García-Campos JA, Alarcón T, Domingo D, Menéndez-Rivas M, López-Brea M.

Rev Esp Quimioter. 2003 Jun;16(2):216-20. Spanish.

50.

A case of endocarditis due to Granulicatella adiacens.

Perkins A, Osorio S, Serrano M, del Ray MC, Sarriá C, Domingo D, López-Brea M.

Clin Microbiol Infect. 2003 Jun;9(6):576-7. No abstract available.

Supplemental Content

Loading ...
Support Center